CN113499469B - Multifunctional antibacterial composite film and preparation method thereof - Google Patents

Multifunctional antibacterial composite film and preparation method thereof Download PDF

Info

Publication number
CN113499469B
CN113499469B CN202110481820.7A CN202110481820A CN113499469B CN 113499469 B CN113499469 B CN 113499469B CN 202110481820 A CN202110481820 A CN 202110481820A CN 113499469 B CN113499469 B CN 113499469B
Authority
CN
China
Prior art keywords
composite film
hydrogen bond
organic framework
preparation
chitosan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110481820.7A
Other languages
Chinese (zh)
Other versions
CN113499469A (en
Inventor
蔡芳昌
叶琴
马宁
章雅
阮波
张鑫珂
张逸捷
蒋涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hubei University
Original Assignee
Hubei University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubei University filed Critical Hubei University
Priority to CN202110481820.7A priority Critical patent/CN113499469B/en
Publication of CN113499469A publication Critical patent/CN113499469A/en
Application granted granted Critical
Publication of CN113499469B publication Critical patent/CN113499469B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/232Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

The invention discloses a multifunctional antibacterial composite film and a preparation method thereof, wherein the preparation method comprises the following steps: dissolving chitosan and polyvinyl alcohol in an acid solution, and stirring for reaction; adding lauramidopropyl betaine, reducing the temperature to 40-60 ℃, continuing to react, then adding a hydrogen bond organic frame, and stirring and mixing for reaction; after the mixture is placed to room temperature, air bubbles are removed, and then the film is dried and uncovered; then with NaHCO 3 Washing the solution to be neutral and drying to obtain the multifunctional antibacterial composite film. According to the invention, chitosan, polyvinyl alcohol, lauramidopropyl betaine and a hydrogen bond organic framework are selected as raw materials, so that the chitosan, the polyvinyl alcohol, the lauramidopropyl betaine and the hydrogen bond organic framework interact to form a compact polymer network, the inherent toughening mechanism of the materials is utilized, the mechanical property of the composite film is obviously enhanced from the aspect of microstructure, and meanwhile, the composite film also has the characteristics of air permeability, moisture absorption, antibiosis, high-load medicine and the like, and the preparation method is simple, the materials are nontoxic and pollution-free, and the composite film has wide application prospect and application value.

Description

Multifunctional antibacterial composite film and preparation method thereof
Technical Field
The invention relates to the technical field of biomedical dressings, in particular to a multifunctional antibacterial composite film and a preparation method thereof.
Background
Medical dressings are articles for dressing wounds, for covering sores, wounds or other lesions of medical material. With the intensive research on the pathophysiology of the wound healing process, people understand the wound healing process more and more deeply, so that medical wound dressings are continuously improved and developed. Traditional medical dressings only have a simple protection function on wounds, such as early-stage flax and cotton dressings, cannot provide a moist environment, are easy to adhere to wounds, are not easy to replace, and cannot achieve a good treatment effect. Currently, polymer dressings capable of keeping skin wounds moist and antibacterial have become the mainstream of development of medical wound dressings. When the antibacterial dressing has more exudates, if the dressing is not replaced in time, the dressing can cause skin around the wound to be soaked, easily infected and ulcerated, so that the ideal medical dressing for the wound has the capability of absorbing the exudates; and the wound dressing has the performances of providing a moist environment for wounds, sufficient oxygen transmission rate, good biocompatibility, proper swelling rate, excellent antibacterial activity and the like.
The hydrogel dressing prepared by the patent has excellent characteristics of diminishing inflammation, relieving wound pain, reducing scars, promoting wound healing, absorbing wound exudate, realizing biocompatibility and the like, but shows poor antibacterial performance and mechanical stability, is easy to cause wound infection, and is easy to curl edges of the dressing, fall off and poor in using effect due to repeated friction. Therefore, a novel multifunctional composite film medical dressing with excellent mechanical properties and antibacterial effect, high swelling rate, oxygen transmission rate and biocompatibility is urgently needed to be designed.
Disclosure of Invention
The invention provides a multifunctional antibacterial composite film and a preparation method thereof aiming at the defects in the prior art, wherein chitosan, polyvinyl alcohol, lauramidopropyl betaine and a hydrogen bond organic framework are selected as raw materials and are interacted to form a compact polymer network, the inherent toughening mechanism of the materials is utilized, the mechanical property of the composite film is obviously enhanced from the microstructure, and meanwhile, the composite film also has the characteristics of air permeability, moisture absorption, antibacterial property, high-load medicine and the like, and the preparation method is simple, the materials are nontoxic and pollution-free, and the multifunctional antibacterial composite film has wide application prospect and application value.
In order to achieve the purpose, the invention adopts the technical scheme that:
the invention provides a preparation method of a multifunctional antibacterial composite film, which comprises the following steps:
step 1, dissolving chitosan and polyvinyl alcohol in an acid solution, and stirring for reaction at 70-90 ℃;
step 2, adding lauramidopropyl betaine, reducing the temperature to 40-60 ℃, continuing to react for 1-3 hours, then adding a hydrogen bond organic framework, and stirring and mixing to react for 8-12 hours;
step 3, after the mixture is placed to room temperature, removing bubbles, drying and uncovering the film;
step 4, naHCO is used for the uncovered membrane 3 Washing the solution to be neutral, and then drying the solution at 35-40 ℃ for 8-12 hours to obtain the multifunctional antibacterial composite film.
Further, the mass ratio w/w of the chitosan, the polyvinyl alcohol and the lauramidopropyl betaine is 1:1 to 3:1 to 3.
Further, the mass ratio w/w of the chitosan, the polyvinyl alcohol and the lauramidopropyl betaine is 1:2:2.
further, the addition amount of the hydrogen bond organic framework is 3wt% of the total mass.
Further, the hydrogen bond organic framework is a 2-dimensional-hydrogen bond organic framework, and the preparation method of the 2-dimensional-hydrogen bond organic framework comprises the following steps:
weighing melamine, pyromellitic dianhydride and zinc chloride, mixing, grinding, sealing in a high-temperature resistant tube, reacting at 200-400 ℃, and then reacting with HCl and H 2 And (3) washing with O, activating with tetrahydrofuran, performing Soxhlet extraction with methanol, and finally drying to obtain the 2-dimensional-hydrogen bond organic framework.
Further, in the preparation method of the 2-dimensional-hydrogen bond organic framework, the w/w of melamine, pyromellitic dianhydride and zinc chloride is 1:2.59:13.53.
further, the acid solution in step 1 is selected from any one or more of hydrochloric acid, sulfuric acid, formic acid and acetic acid.
Further, the acid solution in step 1 is an acetic acid solution with a concentration of 2 wt%.
Further, in step 1, chitosan and polyvinyl alcohol were dissolved in a 2wt% acetic acid solution at a volume ratio v/v 1.
The invention also provides a multifunctional antibacterial composite film which is prepared by the preparation method.
Compared with the prior art, the invention has the beneficial effects that:
(1) According to the invention, on the basis of the traditional chitosan/polyvinyl alcohol hydrogel film, the lauramidopropyl betaine and the hydrogen bond organic framework are added, so that functional groups of all components interact to form a compact polymer network, the mechanical property of the composite film is enhanced, meanwhile, the toughness of the composite film is enhanced by a toughening mechanism caused by the hydrogen bond organic framework, the maximum tensile strength of the composite film can reach 29MPa, and the maximum loading capacity can reach 3700g, namely the mechanical property of the composite film is remarkably improved;
(2) The chitosan and the lauramidopropyl betaine in the composite film are both polycationic compounds, and the bacteria are polyanions, so that the hydrogen bond effect formed by the chitosan, the lauramidopropyl betaine, the polyvinyl alcohol and a hydrogen bond organic frame ensures that the composite film has stronger antibacterial activity;
(3) The composite film also has excellent hydrophilicity, swelling rate, oxygen transmission rate and biocompatibility, namely the multifunctional antibacterial composite film has multiple excellent performances, and meanwhile, the preparation method is simple, the material cost is low, and the multifunctional antibacterial composite film is non-toxic, pollution-free and nuisanceless and has wide application prospects.
Drawings
FIG. 1 is a CS/PVA/LPB/2D-HOF composite membrane prepared in example 1 of the present invention;
FIG. 2 is a diagram illustrating the measurement of the bacteriostatic effect of the CS/PVA/LPB/2D-HOF composite membrane in example 1 of the present invention;
FIG. 3 is a graph showing the results of measuring the antibacterial properties of different films in example 1 of the present invention and comparative examples 1 to 4;
FIG. 4 shows the results of the biocompatibility measurements of different films of example 1 of the present invention and comparative examples 1 to 4;
FIG. 5 is a graph showing the results of measuring the tensile strength and elongation at break of different films in example 1 of the present invention and comparative examples 1 to 4;
FIG. 6 is an FESEM image before and after stretching of a CS/PVA/LPB/2D-HOF composite film according to the present invention;
FIG. 7 is a measurement result of the maximum loading amount of the CS/PVA/LPB/2D-HOF composite membrane according to the present invention;
FIG. 8 is a graph showing the results of measuring the oxygen transmission rate of various films in example 1 of the present invention and comparative examples 1 to 4;
FIG. 9 is a measurement result of swelling ratios of different films in example 1 of the present invention and comparative examples 1 to 4;
FIG. 10 shows the result of measuring the hydrophilic contact angle of the CS/PVA/LPB/2D-HOF composite membrane of the present invention.
Detailed Description
The technical solutions of the present invention will be described clearly and completely with reference to the embodiments of the present invention, and it should be apparent that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
The embodiment provides a multifunctional antibacterial composite film and a preparation method thereof, and the multifunctional antibacterial composite film comprises the following specific steps:
step 1, synthesis of 2-dimensional-hydrogen bond organic framework (2D-HOF): 0.0723g of Melamine (MA), 0.1869g of pyromellitic dianhydride (PMDA) and 0.978g of zinc chloride (ZnCl) were weighed into a glove box 2 ) Mixing, grinding, adding into quartz tube, sealing, and reacting at 300 deg.C in furnace for 72 hours. After the reaction is finished, 1M HCl and H are used in sequence 2 Washing with O, activating with Tetrahydrofuran (THF), performing Soxhlet extraction with methanol, and drying in oven at 85 deg.C overnight to obtain 2D-HOF;
step 2, adding 1g of Chitosan (CS), 2g of polyvinyl alcohol (PVA) and 150mL of 2wt% acetic acid (HAc) solution into a three-neck flask, stirring for 2 hours at 80 ℃, then adding 2g of lauramidopropyl betaine (LPB), reducing the temperature to 55 ℃, continuing to react for 2 hours, adding 3% of 2D-HOF by mass, and stirring for 8-12 hours;
step 3, after the mixed solution is placed at room temperature, vacuumizing the reaction solution for 30min to remove air bubbles in the reaction solution, pouring the solution into a polytetrafluoroethylene disc by a natural salivation method, drying the polytetrafluoroethylene disc in an oven at 50 ℃ for 20 hours, and then uncovering the film;
step 4, naHCO is used for the uncovered mixed membrane 3 Washing the solution to neutrality to remove residual acetic acid on the surface of the membrane, and finally drying the membrane at 37 ℃ for 8-12 hours to finally prepare the CS/PVA/LPB/2D-HOF composite membrane, namely the multifunctional antibacterial composite membrane disclosed by the invention, as shown in figure 1.
The specific action mechanism of the composite membrane is as follows: a hydrogen bond network is formed between the amido of the CS and the hydroxyl of the PVA, LPB contains amido and-COO-, a polymer network is formed between the LPB and the hydroxyl of the CS and the PVA through the action of the hydrogen bond, and a compact polymer network is formed through the interaction between the polymers by the 2D-HOF of a two-dimensional layered structure embedded in the polymer network, so that the mechanical property of the composite film is enhanced. Further, the composite film slides between polymer chains during stretching, hydrogen bonds start to break and absorb breaking energy, and crack bridging is caused between some un-broken HOFs and polymer chains, thereby further enhancing energy consumption and load transfer. Therefore, the mechanical property of the composite film is obviously improved under the combined action of the toughening mechanism caused by the 2D-HOF and the hydrogen bond between the polymers, and the problem of edge curling caused by repeated friction of the traditional dressing is effectively solved.
CS and LPB are both polycationic compounds, and bacteria are polyanionic compounds, and hydrogen bonding effect between the bacteria and PVA and 2D-HOF enables the composite membrane to have strong antibacterial activity. Further, CS and PVA contain a large number of hydrophilic groups (-OH, -NH) 2 ) After the addition of LPB, more groups interact (-OH, -NH) due to the presence of amide groups and-COO-groups of LPB 2 COOH and amido group), the intermolecular force is strengthened, the multi-network structure formed by a plurality of polymers enhances the absorption of water molecules so as to enhance the hydrophilicity of the composite membrane, the adhesive force of human skin fiber cells on the surface of the dressing film is increased, and heat and sweat generated by a human body can be rapidly absorbed and diffused to the outside; meanwhile, the 2D-HOF is a porous material and can increase the oxygen permeability of the composite membrane, so that the composite membrane also has excellent oxygen permeability.
Further, the embodiment also verifies the antibacterial performance of the CS/PVA/LPB/2D-HOF composite membrane prepared by the method, which is specifically as follows: sterilizing composite membrane, and adding into Staphylococcus aureus (S.aureus) (1 × 10) 7 CFU/mL), and 48 hours at 37 ℃ with no composite membrane added as a blank, then the bacterial suspension was diluted 100 ten thousand times and spread in LB medium, and 48 hours were cultured at 37 ℃, and the number of bacterial colonies in both media was counted, as shown in fig. 2. The result shows that almost no bacteria grow after the composite membrane bacterial liquid is added and the composite membrane bacterial liquid is coated, and the CS/PVA/LPB/2D-HOF composite membrane prepared by the invention is proved to have excellent bactericidal and bacteriostatic activity.
Comparative example 1
This comparative example differs from example 1 in that: in the comparative example, the CS film was prepared only from CS as a raw material, and the preparation method thereof was: charging 1g of CS and 150mL of a 2wt% HAc solution into a three-necked flask, stirring at 80 ℃ for 2 hours, then lowering the temperature to 55 ℃, and stirring at 8-12 hours; subsequent steps were the same as steps 3 and 4 in example 1, and a CS film was synthesized.
Comparative example 2
This comparative example differs from example 1 in that: in the comparative example, the PVA film is prepared only by taking PVA as a raw material, and the preparation method comprises the following steps: 2g of PVA and 150mL of a 2wt% HAc solution were charged into a three-necked flask, and 2 hours were stirred at 80 ℃ and then the temperature was lowered to 55 ℃ and 8 to 12 hours were stirred; the subsequent steps were the same as in steps 3 and 4 of example 1, and a PVA film was synthesized.
Comparative example 3
This comparative example differs from example 1 in that: the comparative example only takes CS and PVA as raw materials to prepare the CS/PVA film, and the preparation method comprises the following steps: 1g of CS,2g of PVA and 150mL of a 2wt% HAc solution were charged into a three-necked flask, stirred at 80 ℃ for 2 hours, then cooled to 55 ℃ and stirred for 8 to 12 hours; the subsequent steps were the same as in steps 3 and 4 of example 1, and a CS/PVA film was synthesized.
Comparative example 4
The comparative example differs from example 1 in that: in the comparative example, the CS/PVA/LPB film is prepared only by taking CS, PVA and LPB as raw materials, and the preparation method comprises the following steps: 1g of CS,2g of PVA and 150mL of a 2wt% HAc solution were charged into a three-necked flask, and 2 hours of stirring were carried out at 80 ℃ followed by addition of 2g of LPB, the temperature was lowered to 55 ℃ and stirring was carried out at 8 to 12 hours; the subsequent steps were the same as in steps 3 and 4 of example 1, and a CS/PVA/LPB film was synthesized.
Evaluation protocol
1. Antibacterial property
A total of 4 membranes of example 1 and comparative examples 1, 3 and 4 were cut into a circle with a diameter of 1cm, 4 samples were sterilized with absolute ethanol, then soaked in PBS solution for 12 hours, and finally the experimental equipment and membrane samples were sterilized under an ultraviolet lamp for 30min. 20 μ L of bacteria (S.aureus) (1X 10) 7 CFU/mL)) was diluted with 180. Mu.L of PBS solution and then added to a 96-well plate, the sterilized film sample was placed in the 96-well plate containing the bacterial suspension, and the PBS bacterial suspension without the film sample was used as the bacterial suspensionIs a control group. Culturing 48hour at 37 ℃, then diluting the bacterial suspension by 100 ten thousand times, coating the bacterial suspension in LB culture medium, culturing 48hour at 37 ℃, and recording the number of bacterial colonies containing CS/PVA/LPB/HOF film samples; the Optical Density (OD) values of the control and experimental groups were also measured at a wavelength of 570nm using a microplate reader (Bio Tek, ELX800, USA), and six groups of experiments were performed in parallel for one sample. The antibacterial rate was calculated using the following formula:
Figure BDA0003048772350000071
the measurement results are shown in FIG. 3. The results show that 4 films have excellent antibacterial activity, the antibacterial rate is more than 90%, the antibacterial rates of the CS/PVA film and the CS/PVA/LPB/2D-HOF composite film are relatively high and reach 95%, wherein the antibacterial rate of the CS/PVA/LPB/2D-HOF composite film can reach 95.76%
2. Biocompatibility
In order to detect the biocompatibility of different films, a cytotoxicity test was performed by using the MTT method. The cell compatibility of MC3T3-E1 cells was determined using 3- [4,5-220 dimethylthiazol-2-yl ] -2,5-diphenyltetrazolium bromide (MTT, alad-221din reagents, china).
The film samples were round with a diameter of 1cm and were soaked in PBS (pH = 7.4) solution in advance with a concentration of 1X10 4 Cells/cm 2 200 μ L of the cell suspension of (1) was cultured together with membrane samples (CS membrane, PVA membrane, CS/PVA/LPB/HOF membrane) on a 96-well plate for 3 days (37 ℃ incubator), and the cell suspension without the sample was used as a control group. The cell culture medium was removed and 200. Mu. LMTT solution (0.5 mg mL) was added to each well -1 ) After 4 hours of incubation at 37 ℃ in a cell incubator, the MTT solution was aspirated by a pipette gun, 200. Mu.L of dimethyl sulfoxide (DMSO) was added to each group, and the resulting mixture was centrifuged for 15min to obtain a supernatant, and finally the Optical Density (OD) was measured at a wavelength of 570nm using a microplate reader (Bio Tek, ELX800, USA). Six sets of parallel tests were performed on one sample. Cell activity was calculated using the following formula:
Figure BDA0003048772350000081
the detection results are shown in fig. 4, and the results show that different films have an effect on cell survival rates, wherein the cell survival rates of the CS film, the PVA film and the CS/PVA film are significantly lower than those of the CS/PVA/LPB film and the CS/PVA/LPB/2D-HOF composite film, i.e., the composite film of the invention has excellent biocompatibility, is non-toxic to cells, and can be directly applied to wounds.
3. Tensile strength, elongation at break and maximum load
A total of 5 film samples of example 1 and comparative examples 1-4 were prepared in a dumbbell shape, and the mechanical properties of the different polymer film samples were characterized by an electronic universal (tensile) tester (CMT 4104), with an original gauge length of 20mm and a rate of 2mm/min.
The measurement result is shown in fig. 5, where 5- (a) is tensile strength, and 5- (b) is elongation at break, and the result shows that the tensile strength of the CS/PVA/LPB/2D-HOF composite film of the present invention is significantly improved compared with other film samples, the maximum tensile strength thereof can reach 29MPa, and the elongation at break thereof is also significantly higher than other films, and is as high as 450%, which indicates that the toughness of the CS/PVA/LPB/2D-HOF composite film of the present invention is also significantly improved.
The surface morphology of the CS/PVA/LPB/2D-HOF composite film of the present invention was analyzed using a Field Emission Scanning Electron Microscope (FESEM) (Zeiss Sigma 500) during stretching, the surface morphology of the composite film before stretching and the morphology of the broken portion of the film after stretching with a tensile machine were observed using a field emission scanning electron microscope under a voltage of 15KV for 120sec, and the results of the observation are shown in FIG. 6. In fig. 6, the upper graph is before stretching and the lower graph is after stretching, cracks can be observed in the graphs, i.e. the crack toughening mechanism described in the principle part in example 1 is confirmed.
The maximum loading of the CS/PVA/LPB/2D-HOF composite membrane is measured, the result is shown in figure 7, and the result shows that the maximum loading of the composite membrane can reach 3700g, namely the composite membrane has excellent mechanical properties.
4. Oxygen transmission rate
A total of 5 film samples of example 1 and comparative examples 1 to 4 were prepared in a circular shape having a diameter of 4cm, and each film sample was tested for oxygen permeability (cm) by a differential pressure gas permeameter (VAC-V2) 3 /m 2 24hour 0.1 MPa), each test was performed 6 times, and the measurement results are shown in FIG. 8.
The results show that compared with 4 film samples in comparative examples 1-4, the CS/PVA/LPB/2D-HOF composite film provided by the invention has significantly improved oxygen transmission rate, and the oxygen transmission rate is as follows: 800cm 3 /m 2 24hour 0.1MPa. Therefore, when the air-permeable dressing is used for wounds, the air permeability is better, and the wound healing is more facilitated.
5. Swelling degree and hydrophilicity measurement
A total of 5 film samples of example 1 and comparative examples 1 to 4 were taken, cut into a size of 1cm × 1cm, soaked in PBS buffer (pH =7.4, 37 ℃), taken out every 1d, slowly sucked up water on the surface of the dry film with quantitative filter paper, and then weighed. One sample, six sets of parallel runs, was tested and the swelling ratio was calculated using the following formula: (wherein W d Before soaking in PBS solution, W w Is measured after soaking)
Figure BDA0003048772350000091
The result is shown in fig. 9, and the result shows that compared with other films, due to the addition of LPB and HOF, the hydrophilic functional groups are increased, and the hydrogen bond acting force is improved, so that the CS/PVA/LPB/2D-HOF composite film disclosed by the invention still maintains a higher swelling rate after being soaked in the buffer solution for 7 days, thereby facilitating the absorption of tissue fluid exuded from the wound and providing a moist environment for the wound, promoting the wound healing, providing a clean and clean environment for the wound surface, and simultaneously, the high swelling rate can also contain more drugs or antibacterial agents, thereby facilitating the wound treatment.
Furthermore, a CS/PVA/LPB/2D-HOF composite membrane sample prepared in the embodiment 1 of the invention is prepared into a square with the size of 2 x 2cm, the hydrophilicity of the composite membrane is characterized by a contact angle measuring instrument (POWEREACH JC2000D 1), and the detection result is shown in figure 10.
According to the invention, by combining the determination results, chitosan, polyvinyl alcohol, lauramidopropyl betaine and a hydrogen bond organic framework are selected as raw materials, so that the chitosan, the polyvinyl alcohol, the lauramidopropyl betaine and the hydrogen bond organic framework are interacted to form a compact polymer network, the inherent toughening mechanism of the materials is utilized, the mechanical property of the composite film is obviously enhanced from the aspect of microstructure, and meanwhile, the composite film has the characteristics of air permeability, moisture absorption, antibiosis, high-load medicine and the like, and has wide application prospect and higher application value.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any changes or substitutions that can be easily conceived by those skilled in the art within the technical scope of the present invention are included in the scope of the present invention.

Claims (8)

1. A preparation method of a multifunctional antibacterial composite film is characterized by comprising the following steps:
step 1, dissolving chitosan and polyvinyl alcohol in an acid solution, and stirring for reaction at 70-90 ℃;
step 2, adding lauramidopropyl betaine, reducing the temperature to 40-60 ℃, continuing to react for 1-3 hours, then adding a hydrogen bond organic framework, and stirring and mixing to react for 8-12 hours;
step 3, after the mixture is placed to room temperature, air bubbles are removed, drying is carried out, and the film is uncovered;
step 4, naHCO is used for the uncovered membrane 3 Washing the solution to be neutral, and then drying the solution at 35-40 ℃ for 8-12 hours to obtain the multifunctional antibacterial composite film;
the hydrogen bond organic framework is a 2-dimensional-hydrogen bond organic framework, and the preparation method of the 2-dimensional-hydrogen bond organic framework comprises the following steps: weighing melamine, pyromellitic dianhydride and zinc chloride, mixing, grinding and sealingReaction in a high-temperature tube at 200-400 deg.C, then reaction with HCl and H 2 Washing with O, activating with tetrahydrofuran, performing Soxhlet extraction with methanol, and drying to obtain the 2-dimensional-hydrogen bond organic framework;
in the preparation method of the 2-dimensional-hydrogen bond organic framework, the w/w of melamine, pyromellitic dianhydride and zinc chloride is 1:2.59:13.53.
2. the method according to claim 1, wherein the w/w ratio of the chitosan, polyvinyl alcohol and lauramidopropyl betaine is 1:1 to 3:1 to 3.
3. The method of claim 2, wherein the w/w ratio of the chitosan, polyvinyl alcohol and lauramidopropyl betaine is 1:2:2.
4. the method according to claim 1, wherein the hydrogen bonding organic framework is added in an amount of 3wt% based on the total mass.
5. The method according to claim 1, wherein the acid solution in step 1 is selected from any one or more of hydrochloric acid, sulfuric acid, formic acid, and acetic acid.
6. The method according to claim 5, wherein the acid solution in step 1 is an acetic acid solution having a concentration of 2 wt%.
7. The method of claim 6, wherein the chitosan and polyvinyl alcohol are dissolved in a 2wt% acetic acid solution of v/v 1.
8. A multifunctional antibacterial composite film characterized by being produced by the production method as claimed in any one of claims 1 to 7.
CN202110481820.7A 2021-04-30 2021-04-30 Multifunctional antibacterial composite film and preparation method thereof Active CN113499469B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110481820.7A CN113499469B (en) 2021-04-30 2021-04-30 Multifunctional antibacterial composite film and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110481820.7A CN113499469B (en) 2021-04-30 2021-04-30 Multifunctional antibacterial composite film and preparation method thereof

Publications (2)

Publication Number Publication Date
CN113499469A CN113499469A (en) 2021-10-15
CN113499469B true CN113499469B (en) 2022-10-21

Family

ID=78009211

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110481820.7A Active CN113499469B (en) 2021-04-30 2021-04-30 Multifunctional antibacterial composite film and preparation method thereof

Country Status (1)

Country Link
CN (1) CN113499469B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11479482B1 (en) 2022-05-31 2022-10-25 King Fahd University Of Petroleum And Minerals Hydrogen-bonded organic framework (HOF) for water uptake

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112641995A (en) * 2020-12-21 2021-04-13 上海交通大学 Chiral hydrogel dressing with antibacterial and repair promoting functions and preparation method and application thereof
CN112691231A (en) * 2020-10-29 2021-04-23 广东泰宝医疗科技股份有限公司 Polyvinyl alcohol/sodium alginate/quaternized polyhexamethylene guanidine antibacterial gel and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112691231A (en) * 2020-10-29 2021-04-23 广东泰宝医疗科技股份有限公司 Polyvinyl alcohol/sodium alginate/quaternized polyhexamethylene guanidine antibacterial gel and preparation method thereof
CN112641995A (en) * 2020-12-21 2021-04-13 上海交通大学 Chiral hydrogel dressing with antibacterial and repair promoting functions and preparation method and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Development of the PVA/CS nanofibers containing silk protein sericin as a wound dressing: In vitro and in vivo assessment-Science Direct;Bra B et al;《International Journal of Biological Macromolecules》;20200116;第149卷;摘要,第514页和第516页 *
Effects of loading rates on mode I interlaminar fracture toughness of carbon/epoxy composite toughened by carbon nanotube films;Li Z et al;《Composites Part B Engineering》;20200805;第200卷;摘要,第17页和结论部分 *
多孔氢键有机框架(HOFs):现状与挑战;林祖金等;《化学学报》;20200908(第78期);摘要和第1331-1332页 *

Also Published As

Publication number Publication date
CN113499469A (en) 2021-10-15

Similar Documents

Publication Publication Date Title
Mehrabani et al. Preparation of biocompatible and biodegradable silk fibroin/chitin/silver nanoparticles 3D scaffolds as a bandage for antimicrobial wound dressing
Zhang et al. Zn2+-loaded TOBC nanofiber-reinforced biomimetic calcium alginate hydrogel for antibacterial wound dressing
Di et al. A transparent wound dressing based on bacterial cellulose whisker and poly (2-hydroxyethyl methacrylate)
Namazi et al. Antibiotic loaded carboxymethylcellulose/MCM-41 nanocomposite hydrogel films as potential wound dressing
Devi et al. Development and in vitro characterization of chitosan/starch/halloysite nanotubes ternary nanocomposite films
Lin et al. Preparation of graphene-embedded hydroxypropyl cellulose/chitosan/polyethylene oxide nanofiber membranes as wound dressings with enhanced antibacterial properties
CN111150880A (en) Antibacterial composite hydrogel and preparation method thereof
Fan et al. Preparation and characterization of antibacterial polyvinyl alcohol/chitosan sponge and potential applied for wound dressing
CN101905031B (en) Method for preparing flamazine/bacterial cellulose composite wound dressing
Liu et al. A lignocellulose-based nanocomposite hydrogel with pH-sensitive and potent antibacterial activity for wound healing
CN110229247B (en) Medical dressing based on alginic acid derivative electrospun nano composite fiber membrane and preparation method thereof
Lv et al. Gelatin-based nanofiber membranes loaded with curcumin and borneol as a sustainable wound dressing
Savitskaya et al. Physicochemical and antibacterial properties of composite films based on bacterial cellulose and chitosan for wound dressing materials
CN111166931A (en) Methacrylic acid sericin/chitosan quaternary ammonium salt hydrogel and preparation method and application thereof
CN114949325A (en) Preparation method of composite nanofiber membrane for wound dressing and composite nanofiber membrane
CN113499469B (en) Multifunctional antibacterial composite film and preparation method thereof
Karydis-Messinis et al. Development, physicochemical characterization and in vitro evaluation of chitosan-fish gelatin-glycerol hydrogel membranes for wound treatment applications.
Ding et al. Antibacterial and hemostatic polyvinyl alcohol/microcrystalline cellulose reinforced sodium alginate breathable dressing containing Euphorbia humifusa extract based on microfluidic spinning technology
Li et al. Synergic fabrication of titanium dioxide incorporation into heparin-polyvinyl alcohol nanocomposite: enhanced in vitro antibacterial activity and care of in vivo burn injury
Huang et al. Preparation of multifunctional wound dressings with composite PVA/PE films
Zhao et al. Engineering pH responsive carboxyethyl chitosan and oxidized pectin-based hydrogels with self-healing, biodegradable and antibacterial properties for wound healing
Yi et al. Highly hygroscopicity and antioxidant nanofibrous dressing base on alginate for accelerating wound healing
CN113599579A (en) Double-network hydrogel and preparation method thereof
Fu et al. Liquid handling properties of carboxymethyl modified chitosan nonwovens for medical dressings
CN111184906B (en) PVA-based liquid dressing and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20211015

Assignee: Yunnan Jianze Medical Technology Development Co.,Ltd.

Assignor: Hubei University

Contract record no.: X2023980040030

Denomination of invention: A multifunctional antibacterial composite film and its preparation method

Granted publication date: 20221021

License type: Common License

Record date: 20230822

Application publication date: 20211015

Assignee: Kunming Dechi Environmental Engineering Co.,Ltd.

Assignor: Hubei University

Contract record no.: X2023980040018

Denomination of invention: A multifunctional antibacterial composite film and its preparation method

Granted publication date: 20221021

License type: Common License

Record date: 20230822

Application publication date: 20211015

Assignee: Yunnan El Energy Saving Technology Co.,Ltd.

Assignor: Hubei University

Contract record no.: X2023980040006

Denomination of invention: A multifunctional antibacterial composite film and its preparation method

Granted publication date: 20221021

License type: Common License

Record date: 20230822